Al Hammadi Holding Company (TADAWUL:4007)

Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
41.65
+0.05 (0.12%)
Mar 27, 2025, 3:17 PM AST
-33.25%
Market Cap 6.66B
Revenue (ttm) 1.15B
Net Income (ttm) 338.80M
Shares Out 160.00M
EPS (ttm) 2.12
PE Ratio 19.67
Forward PE 21.81
Dividend 1.40 (3.36%)
Ex-Dividend Date Mar 3, 2025
Volume 481,893
Average Volume 481,328
Open 41.60
Previous Close 41.60
Day's Range 41.35 - 41.90
52-Week Range 37.90 - 61.50
Beta 0.50
RSI 52.18
Earnings Date Mar 16, 2025

About TADAWUL:4007

Al Hammadi Holding Company, a healthcare group, provides various medical services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It engages in the sale of pharmaceutical products. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in August 2022. Al Hammadi Holding Company was founded in 1985 and is based in Riyadh, Saudi Arabia. [Read more]

Sector Healthcare
Founded 1985
Country Saudi Arabia
Stock Exchange Saudi Stock Exchange
Ticker Symbol 4007
Full Company Profile

Financial Performance

In 2024, TADAWUL:4007's revenue was 1.15 billion, a decrease of -1.94% compared to the previous year's 1.18 billion. Earnings were 338.80 million, an increase of 11.69%.

Financial Statements

News

There is no news available yet.